Filing Details
- Accession Number:
- 0001708138-21-000085
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-17 16:02:53
- Reporting Period:
- 2021-11-15
- Accepted Time:
- 2021-11-17 16:02:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1411984 | P Daniel Plew Van | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp & General Mgr, Industrial | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-15 | 25,000 | $270.43 | 51,931 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-11-15 | 18,222 | $641.50 | 33,709 | No | 4 | F | Direct | |
Common Stock | Disposition | 2021-11-16 | 528 | $652.20 | 33,181 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-11-16 | 840 | $653.41 | 32,341 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-11-16 | 1,260 | $654.33 | 31,081 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-11-16 | 350 | $655.03 | 30,731 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-11-16 | 200 | $657.18 | 30,531 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-11-16 | 697 | $658.50 | 29,834 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-11-16 | 2,403 | $659.42 | 27,431 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-11-16 | 500 | $660.51 | 26,931 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-11-15 | 25,000 | $0.00 | 25,000 | $270.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2023-12-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,048 | Indirect | By 401(k) Plan |
Footnotes
- Represents volume-weighted average price of sales of 528 shares of Company stock on November 16, 2021 at prices ranging from $652.01 to $652.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
- Represents volume-weighted average price of sales of 840 shares of Company stock on November 16, 2021 at prices ranging from $653.03 to $653.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
- Represents volume-weighted average price of sales of 1,260 shares of Company stock on November 16, 2021 at prices ranging from $654.03 to $654.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
- Represents volume-weighted average price of sales of 350 shares of Company stock on November 16, 2021 at prices ranging from $655.01 to $655.07. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on November 16, 2021 at prices ranging from $657.09 to $657.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
- Represents volume-weighted average price of sales of 697 shares of Company stock on November 16, 2021 at prices ranging from $658.03 to $658.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
- Represents volume-weighted average price of sales of 2,403 shares of Company stock on November 16, 2021 at prices ranging from $659.01 to $659.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
- Represents volume-weighted average price of sales of 500 shares of Company stock on November 16, 2021 at prices ranging from $660.33 to $660.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.